Health
Study shows vaccine’s potential to stop viral spread – The Australian Financial Review
The news is potentially good for Australia as the Oxford-AstraZeneca vaccine is being manufactured onshore by CSL.
The study design focused on the interval between the two jabs and how this affected the level of protection against becoming ill with COVID-19.
But it covered transmission too, as the Oxford University newsletter explains:
The authors also report further on the potential for the vaccine to reduce transmission of the virus, based on swabs obtained from volunteers in the UK arms of the trial with a 67 per cent reduction after the first dose of the vaccine.
But they say the data is preliminary and…
-
Noosa News23 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News23 hours agoE-biker charged with riding dangerously, assaulting cop
-
General22 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Business16 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today